Literature DB >> 26524075

Ventilator-Associated Events in Neonates and Children--A New Paradigm.

Noelle M Cocoros1, Ken Kleinman, Gregory P Priebe, James E Gray, Latania K Logan, Gitte Larsen, Julia Sammons, Philip Toltzis, Irina Miroshnik, Kelly Horan, Michael Burton, Shannon Sims, Marvin Harper, Susan Coffin, Thomas J Sandora, Susan N Hocevar, Paul A Checchia, Michael Klompas, Grace M Lee.   

Abstract

OBJECTIVES: To identify a pediatric ventilator-associated condition definition for use in neonates and children by exploring whether potential ventilator-associated condition definitions identify patients with worse outcomes.
DESIGN: Retrospective cohort study and a matched cohort analysis.
SETTING: Pediatric, cardiac, and neonatal ICUs in five U.S. hospitals. PATIENTS: Children 18 years old or younger ventilated for at least 1 day.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We evaluated the evidence of worsening oxygenation via a range of thresholds for increases in daily minimum fraction of inspired oxygen (by 0.20, 0.25, and 0.30) and daily minimum mean airway pressure (by 4, 5, 6, and 7 cm H2O). We required worsening oxygenation be sustained for at least 2 days after at least 2 days of stability. We matched patients with a ventilator-associated condition to those without and used Cox proportional hazard models with frailties to examine associations with hospital mortality, hospital and ICU length of stay, and duration of ventilation. The cohort included 8,862 children with 10,209 hospitalizations and 77,751 ventilator days. For the fraction of inspired oxygen 0.25/mean airway pressure 4 definition (i.e., increase in minimum daily fraction of inspired oxygen by 0.25 or mean airway pressure by 4), rates ranged from 2.9 to 3.2 per 1,000 ventilator days depending on ICU type; the fraction of inspired oxygen 0.30/mean airway pressure 7 definition yielded ventilator-associated condition rates of 1.1-1.3 per 1,000 ventilator days. All definitions were significantly associated with greater risk of hospital death, with hazard ratios ranging from 1.6 (95% CI, 0.7-3.4) to 6.8 (2.9-16.0), depending on thresholds and ICU type. Each definition was associated with prolonged hospitalization, time in ICU, and duration of ventilation, among survivors. The advisory board of the study proposed using the fraction of inspired oxygen 0.25/mean airway pressure 4 thresholds to identify pediatric ventilator-associated conditions in ICUs.
CONCLUSIONS: Pediatric patients with ventilator-associated conditions are at substantially higher risk for mortality and morbidity across ICUs, regardless of thresholds used. Next steps include identification of risk factors, etiologies, and preventative measures for pediatric ventilator-associated conditions.

Entities:  

Mesh:

Year:  2016        PMID: 26524075     DOI: 10.1097/CCM.0000000000001372

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  9 in total

1.  The Conflicting Paradigm of Ventilator-Associated Conditions.

Authors:  Robinder G Khemani; Lincoln Smith
Journal:  Pediatr Crit Care Med       Date:  2017-11       Impact factor: 3.624

2.  Application of the New Centers for Disease Control and Prevention Surveillance Criteria for Ventilator-Associated Events to a Cohort of PICU Patients Identifies Different Patients Compared With the Previous Definition and Physician Diagnosis.

Authors:  Katherine M Ziegler; Jonathan D Haywood; Marci K Sontag; Peter M Mourani
Journal:  Crit Care Med       Date:  2019-07       Impact factor: 7.598

3.  Diagnostic Stewardship of Endotracheal Aspirate Cultures in a PICU.

Authors:  Anna C Sick-Samuels; Matthew Linz; Jules Bergmann; James C Fackler; Sean M Berenholtz; Shawn L Ralston; Katherine Hoops; Joe Dwyer; Elizabeth Colantuoni; Aaron M Milstone
Journal:  Pediatrics       Date:  2021-04-07       Impact factor: 7.124

4.  Fluid Overload and Kidney Injury Score as a Predictor for Ventilator-Associated Events.

Authors:  Jarin Vaewpanich; Ayse Akcan-Arikan; Jorge A Coss-Bu; Curtis E Kennedy; Jeffrey R Starke; Satid Thammasitboon
Journal:  Front Pediatr       Date:  2019-05-22       Impact factor: 3.418

5.  Practice Improvement for Standardized Evaluation and Management of Acute Tracheitis in Mechanically Ventilated Children.

Authors:  Jennifer Ormsby; Paula Conrad; Jennifer Blumenthal; Jane Carpenter; Sarah Jones; Thomas J Sandora; Ana Vaughan; Julie Vincuilla; Alexander J McAdam; Louis F Fogg; Kelly Flett; Daniel P Kelly
Journal:  Pediatr Qual Saf       Date:  2020-12-28

6.  Evaluation of the applicability of the current CDC pediatric ventilator-associated events (PedVAE) surveillance definition in the neonatal intensive care unit population.

Authors:  Novisi Arthur; Ishminder Kaur; Alison J Carey
Journal:  BMC Pediatr       Date:  2022-04-07       Impact factor: 2.125

Review 7.  Practice Summary of Antimicrobial Therapy for Commonly Encountered Conditions in the Neonatal Intensive Care Unit: A Canadian Perspective.

Authors:  Joseph Y Ting; Julie Autmizguine; Michael S Dunn; Julie Choudhury; Julie Blackburn; Shikha Gupta-Bhatnagar; Katrin Assen; Julie Emberley; Sarah Khan; Jessica Leung; Grace J Lin; Destiny Lu-Cleary; Frances Morin; Lindsay L Richter; Isabelle Viel-Thériault; Ashley Roberts; Kyong-Soon Lee; Erik D Skarsgard; Joan Robinson; Prakesh S Shah
Journal:  Front Pediatr       Date:  2022-07-08       Impact factor: 3.569

8.  Effectiveness of a Daily Rounding Checklist on Processes of Care and Outcomes in Diverse Pediatric Intensive Care Units Across the World.

Authors:  Rahul Kashyap; Srinivas Murthy; Grace M Arteaga; Yue Dong; Lindsey Cooper; Tanja Kovacevic; Chetak Basavaraja; Hong Ren; Lina Qiao; Guoying Zhang; Kannan Sridharan; Ping Jin; Tao Wang; Ilisapeci Tuibeqa; An Kang; Mandyam Dhanti Ravi; Ebru Ongun; Ognjen Gajic; Sandeep Tripathi
Journal:  J Trop Pediatr       Date:  2021-07-02       Impact factor: 1.165

9.  A glass half-full: defining ventilator-associated pneumonia in the neonatal intensive care unit.

Authors:  Emily D Whitesel; Munish Gupta
Journal:  Pediatr Res       Date:  2020-04-02       Impact factor: 3.756

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.